KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Shares Outstanding (Weighted Average) (2016 - 2026)

Bristol Myers Squibb has reported Shares Outstanding (Weighted Average) over the past 18 years, most recently at $2.0 billion for Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.34% to $2.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Mar 2026, changed 0.34% year-over-year, with the annual reading at $2.0 billion for FY2025, 0.35% changed from the prior year.
  • Shares Outstanding (Weighted Average) was $2.0 billion for Q1 2026 at Bristol Myers Squibb, roughly flat from $2.0 billion in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $2.1 billion in Q1 2022 and troughed at $2.0 billion in Q1 2024.
  • The 5-year median for Shares Outstanding (Weighted Average) is $2.0 billion (2026), against an average of $2.1 billion.
  • Year-over-year, Shares Outstanding (Weighted Average) fell 4.44% in 2022 and then grew 0.4% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.1 billion in 2022, then fell by 2.86% to $2.1 billion in 2023, then fell by 2.03% to $2.0 billion in 2024, then grew by 0.35% to $2.0 billion in 2025, then grew by 0.2% to $2.0 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Shares Outstanding (Weighted Average) are $2.0 billion (Q1 2026), $2.0 billion (Q4 2025), and $2.0 billion (Q3 2025).